怎样找一个靠谱的网投

X

Newsroom

28-04-2020

Accord Healthcare ready to fill UK COVID drug shortages

Accord Healthcare announces a significant change to the way the UK receives hydroxychloroquine (HCQ), a medicine under investigation during COVID-19. 

Read More
17-04-2020

Accord Healthcare addresses shortages of critical ventilator medicines for COVID-19 patients

怎样找一个靠谱的网投The Department of Health and Social Care (DHSC) announced yesterday, 16 April 2020  that the UK’s supplies of the vital muscle relaxant medicines (atracurium and cisatracurium) used in patients on mechanical ventilators will be exhausted in the next few days via the MHRA.

Read More
09-04-2020

Viva Italia

怎样找一个靠谱的网投Our team in Italy were asked by Medicines for Europe and the ASSOGENERICI (Italian G

Read More
01-04-2020

Accord Healthcare in the News – BBC Feature 26 March 2020

怎样找一个靠谱的网投Accord Healthcare featured on the BBC 

Read More
31-03-2020

Accord donates two million tablets of hydroxychloroquine to largest COVID-19 trial in the world involving 40,000 frontline healthcare workers

Accord Healthcare Ltd is collaborating on a large multi-national study into the prevention of COVID-19 infection using hydroxychloroquine, a drug that may have an effect in preventing and/or reducing symptoms of COVID-19, in line with the WHO's targeted research priorities.

Read More
02-03-2020

Supporting the next generation of digital pharmacies

怎样找一个靠谱的网投Online pharmacies are on the rise and their growth rate has doubled.

Read More
07-02-2020

FMD One Year on

Putting patients at the heart is what we believe in at Accord. 

Read More
29-01-2020

Leading the conversation on Growth in Pharmaceuticals with Generics Bulletin and Scrip

Showcasing our expertise around innovative growth, Accord recently partnered with Generics Bulletin and Scrip to host a round table of pharma professionals including Clinigen, Mylan, BC Partners and Medichem to discuss growth in the industry.

Read More
22-02-2019

International suppliers meet at Accord Fawdon to celebrate growing together in partnership

Accord Fawdon recently hosted a special event to celebrate its supplier partnerships. 

Read More
12-02-2019

Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare

Taipei, Taiwan and Harrow, England, February 11, 2019 – An exclusive license agreement for the commercialisation of Foresee Pharmaceutical’s (6576.TWO) novel FP-001 program (leuprorelin depot), Leuprolide Mesylate Injectable Suspension (LMIS) ready-to-use subcutaneous depot formulations has been granted to Accord Healthcare.

Read More
手机棋牌输了几百万 快钱彩票官网 怎么购买手机赌博软件 我爱彩票邀请码是多少 怎么样进入赌单双软件 快乐棋牌游戏 手机版彩票过滤工具 怎么下载波克棋牌 我想查查彩票开奖结果 怎么举报网络彩票